NCT02506647View on ClinicalTrials.gov

PK/PD Study of Gan & Lee's Insulin Glargine Injection in Comparison to Lantus in Type 1 Diabetes

PHASE1CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

December 31, 2015

Primary Completion Date

September 30, 2016

Study Completion Date

September 30, 2016

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

Gan & Lee insulin glargine followed by Lantus

0.4 IU/kg Gan \& Lee insulin glargine injection SC, Lantus 0.4 IU/kg injection SC

DRUG

Lantus followed by Gan & Lee insulin glargine

Lantus 0.4 IU/kg injection SC, 0.4 IU/kg Gan \& Lee insulin glargine injection SC,

Trial Locations (1)

91911

Profil Institute for Clinical Research, San Diego

Sponsors
All Listed Sponsors
lead

Gan and Lee Pharmaceuticals, USA

INDUSTRY